Abstract
Purpose
Flexible fiberoptic bronchoscopy (FFB) is a major diagnostic tool commonly used in intensive care unit (ICU). However, it generates discomfort and pain and can worsen respiratory and/or hemodynamic condition of critically ill patients. Remifentanil is an ultrashort-acting opioid drug that has been shown to provide effective sedation for painful procedures in spontaneous breathing patients. The aim of this study is to evaluate the safety and efficacy of sedation with remifentanil target-controlled infusion (Remi-TCI) in patients with spontaneous ventilation undergoing FFB in ICU.
Methods
Monocentric prospective study. All patients received Remi-TCI with initial effect-site target concentration of 2 ng/mL, progressively titrated according to their comfort and sedation. Respiratory and hemodynamic parameters were assessed before, during, and after the procedure, as well as comfort, level of sedation, FFB conditions, and recovery patterns. Global Remi-TCI data and potential complications of the procedure were also recorded.
Results
Fourteen patients were included. FFB was successful in all patients with good conditions (sedation, global comfort, and cough). No severe hemodynamic or respiratory complications occurred during procedure. Maximum target concentration and total dose of remifentanil were 2.5 ng/mL (2–4 ng/mL) and 1.4 μg/kg (0.7–2.4 μg/kg), respectively, over 10 min. Patients reported low level of pain and good satisfaction with the procedure.
Conclusions
FFB under sedation with Remi-TCI seems to be safe and effective in critically ill patients with spontaneous ventilation. Such results could be the first step towards wider use of Remi-TCI in patients experiencing awkward and/or painful procedures in this setting.
Similar content being viewed by others
References
Gruson D, Hilbert G, Valentino R, Vargas F, Chene G, Bebear C, Allery A, Pigneux A, Gbikpi-Benissan G, Cardinaud JP (2000) Utility of fiberoptic bronchoscopy in neutropenic patients admitted to the intensive care unit with pulmonary infiltrates. Crit Care Med 28:2224–2230
Turner JS, Willcox PA, Hayhurst MD, Potgieter PD (1994) Fiberoptic bronchoscopy in the intensive care unit—a prospective study of 147 procedures in 107 patients. Crit Care Med 22:259–264
Trouillet JL, Guiguet M, Gibert C, Fagon JY, Dreyfuss D, Blanchet F, Chastre J (1990) Fiberoptic bronchoscopy in ventilated patients. Evaluation of cardiopulmonary risk under midazolam sedation. Chest 97:927–933
Matot I, Kramer MR (2000) Sedation in outpatient bronchoscopy. Respir Med 94:1145–1153
de Padua AI, de Castro M, Schmidt A, Coutinho Neto J, Terra Filho J, Martinez JA (2004) Clonidine as a pre-anesthetic agent for flexible bronchoscopy. Respir Med 98:746–751
Gonzalez R, De-La-Rosa-Ramirez I, Maldonado-Hernandez A, Dominguez-Cherit G (2003) Should patients undergoing a bronchoscopy be sedated? Acta Anaesthesiol Scand 47:411–415
Hwang J, Jeon Y, Park HP, Lim YJ, Oh YS (2005) Comparison of alfetanil and ketamine in combination with propofol for patient-controlled sedation during fiberoptic bronchoscopy. Acta Anaesthesiol Scand 49:1334–1338
Putinati S, Ballerin L, Corbetta L, Trevisani L, Potena A (1999) Patient satisfaction with conscious sedation for bronchoscopy. Chest 115:1437–1440
Ryu JH, Lee SW, Lee JH, Lee EH, Do SH, Kim CS (2012) Randomized double-blind study of remifentanil and dexmedetomidine for flexible bronchoscopy. Br J Anaesth 108:503–511
Colt HG, Morris JF (1990) Fiberoptic bronchoscopy without premedication. A retrospective study. Chest 98:1327–1330
Purugganan RV (2008) Intravenous anesthesia for thoracic procedures. Curr Opin Anaesthesiol 21:1–7
Abu-Shahwan I, Mack D (2007) Propofol and remifentanil for deep sedation in children undergoing gastrointestinal endoscopy. Paediatr Anaesth 17:460–463
Berkenbosch JW, Graff GR, Stark JM, Ner Z, Tobias JD (2004) Use of a remifentanil-propofol mixture for pediatric flexible fiberoptic bronchoscopy sedation. Paediatr Anaesth 14:941–946
Lallo A, Billard V, Bourgain JL (2009) A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg 108:852–857
Machata AM, Gonano C, Holzer A, Andel D, Spiss CK, Zimpfer M, Illievich UM (2003) Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. Anesth Analg 97:904–908
Neidhart G, Bremerich DH, Kessler P (2001) Fiberoptic intubation during remifentanil propofol sedation. Anaesthesist 50:242–247
Puchner W, Egger P, Puhringer F, Lockinger A, Obwegeser J, Gombotz H (2002) Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiol Scand 46:350–354
Yeganeh N, Roshani B, Azizi B, Almasi A (2010) Target-controlled infusion of remifentanil to provide analgesia for awake nasotracheal fiberoptic intubations in cervical trauma patients. J Trauma 69:1185–1190
Billard V (2009) Anesthésie intraveineuse à objectif de concentration de morphinique en pratique clinique. Le praticien en anesthésie réanimation 13:34–40
De Castro V, Godet G, Mencia G, Raux M, Coriat P (2003) Target-controlled infusion for remifentanil in vascular patients improves hemodynamics and decreases remifentanil requirement. Anesth Analg 96:33–38
Rai MR, Parry TM, Dombrovskis A, Warner OJ (2008) Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. Br J Anaesth 100:125–130
Olofsen E, Boom M, Nieuwenhuijs D, Sarton E, Teppema L, Aarts L, Dahan A (2010) Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers. Anesthesiology 112:1382–1395
De Vito A, Agnoletti V, Berrettini S, Piraccini E, Criscuolo A, Corso R, Campanini A, Gambale G, Vicini C (2011) Drug-induced sleep endoscopy: conventional versus target controlled infusion techniques—a randomized controlled study. Eur Arch Otorhinolaryngol 268:457–462
Gueret G, Billard V, Bourgain JL (2007) Fibre-optic intubation teaching in sedated patients with anticipated difficult intubation. Eur J Anaesthesiol 24:239–244
Clouzeau B, Bui HN, Guilhon E, Grenouillet-Delacre M, Leger MS, Saghi T, Pillot J, Filloux B, Coz S, Boyer A, Vargas F, Gruson D, Hilbert G (2011) Fiberoptic bronchoscopy under noninvasive ventilation and propofol target-controlled infusion in hypoxemic patients. Intensive Care Med 37:1969–1975
Chastre J, Trouillet JL, Vuagnat A, Joly-Guillou ML, Clavier H, Dombret MC, Gibert C (1998) Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 157:1165–1172
Acknowledgments
Ludivine Chalumeau-Lemoine: conception and design of study, acquisition of data, analysis and interpretation of data, drafting the article, approval of the final version. Annabelle Stoclin: conception and design of study, interpretation of data, approval of the final version. Bruno Raynard: conception and design of study, acquisition of data, approval of the final version. Agnès Laplanche: analysis and interpretation of data, approval of the final version. Valérie Billard, François Blot: conception and design of study, analysis and interpretation of data, codrafting the article, and approval of the final version.
Conflicts of interest
The authors declare no financial conflict of interest with both Fresenius Vial and GlaxoSmithKline companies.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chalumeau-Lemoine, L., Stoclin, A., Billard, V. et al. Flexible fiberoptic bronchoscopy and remifentanil target-controlled infusion in ICU: a preliminary study. Intensive Care Med 39, 53–58 (2013). https://doi.org/10.1007/s00134-012-2697-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-012-2697-7